Release of angiotensin converting enzyme by the lung after Pseudomonas bacteremia in sheep.
Open Access
- 1 July 1981
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 68 (1) , 163-170
- https://doi.org/10.1172/jci110232
Abstract
We studied release of angiotensin-converting enzyme (ACE) by the lung after acute injury associated with an increase in pulmonary vascular permeability. In eight adult sheep with chronic lung lymph fistulas, we measured lymph flow (QL), and both ACE activity and total protein content in lymph and plasma under base-line conditions and during 24 h after an infusion of live pseudomonas organism. Under base-line conditions, ACE activity in plasma was 4.93 +/- 0.43 U/ml (mean +/- SEM). The [lymph]/[plasma] ([L]/[P]) ratio for ACE was 0.93 +/- 0.18, compared with a ratio of 0.79 +/- 0.08 for albumin (mean +/- SD). We estimated the molecular weight of ovine ACE to be 145,000 by gel chromatography. Predicted [L]/[P] ratio for a molecule this size is 0.51. Thus, a substantial fraction of ACE activity detected lung lymph under base-line conditions (11.1 +/- 6.2 U/h; mean +/- SD) originated in the lung, and did not diffuse passively from plasma. After pseudomonas infusion, endothelial injury was demonstrated by a rise in pulmonary vascular clearance for total protein (Crp = QL X [L]/[P]). Crp = 3.1 +/- 0.6 ml/h before pseudomonas bacteremia, and rose to 6.7 +/- 1.2 ml/h by 2 h after onset of the infusion (means +/- SEM, p less than 0.05). Crp remained significantly elevated for at least 10 h after the infusion. Release of ACE into lung lymph doubled after acute lung injury and equaled 22.3 +/- 13.8 U/h at 4 h after onset of the infusion. ACE secretion into lung lymph had returned to baseline levels by 24 h after bacteremia. We did not observe a significant rise in plasma ACE activity after acute lung injury. Pseudomonas bacteremia in sheep results in acute, reversible lung injury associated with increased pulmonary vascular permeability, and increased release of ACE by the lung. Failure to detect a rise in plasma ACE content might result from dilution in the large vascular pool or rapid catabolism of the enzyme at some site distant from the lung.This publication has 46 references indexed in Scilit:
- Noninvasive measurement of pulmonary transvascular protein flux in normal man.Journal of Clinical Investigation, 1980
- ANGIOTENSIN-CONVERTING ENZYME IN BRONCHOALVEOLAR LINING FLUIDThe Lancet, 1979
- Angiotensin metabolism by cultured human vascular endothelial and smooth muscle cellsMicrovascular Research, 1979
- SERUM ANGIOTENSIN-CONVERTING ENZYME (SACE) IN SARCOIDOSIS AND OTHER GRANULOMATOUS DISORDERSThe Lancet, 1978
- Purification and Properties of Angiotensin I-Converting Enzyme from Human Lung : VII CONFERENCE ON THE PATHOGENESIS OF HYPERTENSIONJapanese Circulation Journal, 1978
- Scanning (SEM) and transmission (TEM) electron-microscopic studies on post-ischemic endothelial lesions following recirculationAtherosclerosis, 1976
- The Adult Respiratory Distress SyndromeAnnual Review of Medicine, 1976
- Angiotensin-I-converting enzyme activity in idiopathic respiratory distress syndrome of the newborn infant and in experimental alveolar hypoxia in miceThe Journal of Pediatrics, 1975
- Increased Sheep Lung Vascular Permeability Caused by Pseudomonas BacteremiaJournal of Clinical Investigation, 1974
- Conversion of Angiotensin I to Angiotensin IINature, 1967